| Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes CJM Loomans, EJP de Koning, FJT Staal, MB Rookmaaker, C Verseyden, ... Diabetes 53 (1), 195-199, 2004 | 1157 | 2004 |
| Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial L Bax, AJJ Woittiez, HJ Kouwenberg, WPTM Mali, E Buskens, FJA Beek, ... Annals of internal medicine 150 (12), 840-848, 2009 | 863 | 2009 |
| The severe cardiorenal syndrome:‘Guyton revisited’ LG Bongartz, MJ Cramer, PA Doevendans, JA Joles, B Braam European heart journal 26 (1), 11-17, 2005 | 756 | 2005 |
| Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients CE van Iperen, CAJM Gaillard, RJ Kraaijenhagen, BG Braam, JJM Marx, ... Critical care medicine 29 (9), S193-S198, 2001 | 311 | 2001 |
| Mechanisms of disease: erythropoietin resistance in patients with both heart and kidney failure K Van der Putten, B Braam, KE Jie, CAJM Gaillard Nature clinical practice Nephrology 4 (1), 47-57, 2008 | 271 | 2008 |
| Assessment of renal autoregulation WA Cupples, B Braam American Journal of Physiology-Renal Physiology 292 (4), F1105-F1123, 2007 | 229 | 2007 |
| Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats. LG Navar, L Lewis, A Hymel, B Braam, KD Mitchell Journal of the American Society of Nephrology 5 (4), 1153-1158, 1994 | 222 | 1994 |
| Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology TJ Rabelink, KAH Kaasjager, P Boer, EG Stroes, B Braam, HA Koomans Kidney international 46 (2), 376-381, 1994 | 212 | 1994 |
| Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI) PA McCullough, JA Kellum, M Haase, C Müller, K Damman, PT Murray, ... ADQI Consensus on AKI Biomarkers and Cardiorenal Syndromes 182, 82-98, 2013 | 192 | 2013 |
| Empagliflozin blunts worsening cardiac dysfunction associated with reduced NLRP3 (nucleotide-binding domain-like receptor protein 3) inflammasome activation in heart failure NJ Byrne, N Matsumura, ZH Maayah, M Ferdaoussi, S Takahara, ... Circulation: Heart Failure 13 (1), e006277, 2020 | 187 | 2020 |
| Cardiorenal syndrome—current understanding and future perspectives B Braam, JA Joles, AH Danishwar, CA Gaillard Nature Reviews Nephrology 10 (1), 48-55, 2014 | 177 | 2014 |
| Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system MA Osman, M Alrukhaimi, GE Ashuntantang, E Bellorin-Font, MB Gharbi, ... Kidney international supplements 8 (2), 52-63, 2018 | 160 | 2018 |
| Tetrahydrobiopterin, but Not l-Arginine, Decreases NO Synthase Uncoupling in Cells Expressing High Levels of Endothelial NO Synthase LM Bevers, B Braam, JA Post, AJ van Zonneveld, TJ Rabelink, ... Hypertension 47 (1), 87-94, 2006 | 160 | 2006 |
| Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors KE Jie, MC Verhaar, MJM Cramer, K Van Der Putten, CAJM Gaillard, ... American Journal of Physiology-Renal Physiology 291 (5), F932-F944, 2006 | 140 | 2006 |
| Perinatal l-Arginine and Antioxidant Supplements Reduce Adult Blood Pressure in Spontaneously Hypertensive Rats S Racasan, B Braam, DM van der Giezen, R Goldschmeding, P Boer, ... Hypertension 44 (1), 83-88, 2004 | 132 | 2004 |
| The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the … L Bax, WP Mali, E Buskens, HA Koomans, JJ Beutler, B Braam, FJ Beek, ... Journal of nephrology 16 (6), 807-812, 2003 | 126 | 2003 |
| Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure B Braam, WA Cupples, JA Joles, C Gaillard Heart failure reviews 17, 161-175, 2012 | 124 | 2012 |
| Hepcidin‐25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients K van der Putten, KE Jie, D van den Broek, RJ Kraaijenhagen, ... European journal of heart failure 12 (9), 943-950, 2010 | 113 | 2010 |
| Everything we always wanted to know about furosemide but were afraid to ask X Huang, E Dorhout Mees, P Vos, S Hamza, B Braam American Journal of Physiology-Renal Physiology 310 (10), F958-F971, 2016 | 112 | 2016 |
| Cardiorenal syndrome type 3: pathophysiologic and epidemiologic considerations SM Bagshaw, EA Hoste, B Braam, C Briguori, JA Kellum, PA McCullough, ... ADQI Consensus on AKI Biomarkers and Cardiorenal Syndromes 182, 137-157, 2013 | 112 | 2013 |
